No Data
No Data
Yifan Pharmaceutical (SZSE:002019) Has A Pretty Healthy Balance Sheet
yifan pharmaceutical (002019.SZ): Pimin Xiaojiao Capsules received regulatory approval in Singapore.
yifan pharmaceutical (002019.SZ) announced that its wholly-owned subsidiary, SciGenPte.Ltd....
Yifan Pharmaceutical's Unit Gets Nod to Market Famotidine Injection
Yifan Pharmaceutical (002019.SZ): Wholly-owned subsidiary Famosi Injection receives pharmaceutical registration certificate.
Yifan Pharmaceutical (002019.SZ) announced on September 18 that its wholly-owned subsidiary, Hefei Yifan Biopharmaceutical Co., Ltd., has recently received the "Drug Registration Certificate" for Famotidine Injection issued by the National Medical Products Administration. Famotidine Injection is mainly used for upper gastrointestinal bleeding caused by peptic ulcers, as well as gastric and duodenal mucosal erosion bleeding caused by various reasons other than tumors and esophageal and gastric fundus varices.
Further Weakness as Yifan Pharmaceutical (SZSE:002019) Drops 3.2% This Week, Taking Three-year Losses to 40%
Yifan Pharmaceutical (002019.SZ) interim equity distribution: 1 yuan per 10 shares.
yifan pharmaceutical (002019.SZ) announced that the company's 2024 interim equity distribution scheme is: to distribute equity to shareholders for half a year...
No Data
No Data